IOL Chemicals & Pharmaceuticals Ltd Quarterly Results, Profit & Loss, Balance Sheet (IOLCP) | Stocksigma

IOL Chemicals & Pharmaceuticals Ltd (IOLCP) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

IOL Chemicals & Pharmaceuticals Ltd reported sales of ₹795 Cr, operating profit of ₹109 Cr (OPM 14%) and net profit of ₹65 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

IOLCP quarterly results (₹ Cr)
Metric	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	523	528	552	568	580	619	756	795
Expenses	476	465	490	510	523	527	653	686
Operating Profit	47	63	62	57	57	92	103	109
OPM	9%	12%	11%	10%	10%	15%	14%	14%
Other Income	4	5	7	7	-6	2	8	6
Interest	4	4	4	3	4	3	4	5
Depreciation	19	19	20	20	20	20	21	22
Profit before tax	28	45	46	40	28	71	87	87
Tax	26%	30%	25%	26%	25%	25%	26%	25%
Net Profit	21	31	34	30	21	53	64	65
EPS in Rs	0.7	1.07	1.16	1.02	0.7	1.81	2.19	2.22

IOLCP profit & loss, annual (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	2,184	2,217	2,133	2,079	2,319	2,751
Expenses	1,925	1,991	1,902	1,877	2,049	2,388
Operating Profit	259	226	231	202	270	363
OPM	12%	10%	11%	10%	12%	13%
Other Income	17	25	30	22	9	10
Interest	8	16	16	15	15	16
Depreciation	43	46	63	72	80	84
Profit before tax	225	189	182	138	184	272
Tax	25%	26%	26%	27%	25%	-
Net Profit	168	139	134	101	138	203
EPS in Rs	5.71	4.74	4.58	3.44	4.69	6.92
Dividend Payout	14%	17%	22%	23%	21%	-

IOLCP balance sheet (₹ Cr)
Metric	Mar 2024	Mar 2025	Sep 2025	Mar 2026	Sep 2026
Equity Capital	59	59	59	59	59
Reserves	1,553	1,629	1,693	1,740	1,867
Borrowings	33	117	159	135	201
Other Liabilities	600	577	503	653	704
Total Liabilities	2,244	2,382	2,413	2,587	2,831
Fixed Assets	933	1,171	1,142	1,182	1,191
CWIP	101	22	64	96	189
Investments	20	21	21	21	21
Other Assets	1,190	1,169	1,186	1,289	1,429
Total Assets	2,244	2,382	2,413	2,587	2,831

IOLCP cash flows (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	93	122	290	179	214
Cash from Investing Activity	-121	-120	-191	-154	-198
Cash from Financing Activity	-2	-4	-92	46	-29
Net Cash Flow	-29	-2	6	70	-13
Free Cash Flow	-58	-87	17	-34	43
CFO/OP	60%	75%	144%	97%	93%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit	60	75	144	97	93

IOLCP ratios
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	79	83	81	90	95
Inventory Days	95	77	111	95	91
Days Payable	95	74	123	112	118
Cash Conversion Cycle	79	86	69	73	68
Working Capital Days	71	72	71	58	53
ROCE	-	14%	12%	9%	11%